Overview

A Study in Depression and Associated Painful Physical Symptoms

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if 60 mg of duloxetine given once a day by mouth for 8 weeks to patients diagnosed with major depressive disorder, who also report associated painful physical symptoms, is better than placebo when treating depression and its associated painful symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride